We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$17.8B
AUM Growth
-$2.39B
Cap. Flow
-$2.67B
Cap. Flow %
-15.05%
Top 10 Hldgs %
50.86%
Holding
81
New
3
Increased
21
Reduced
27
Closed
26

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$613M
2
CI icon
Cigna
CI
+$330M
3
HUM icon
Humana
HUM
+$284M
4
FMC icon
FMC
FMC
+$206M
5
CSC
Computer Sciences
CSC
+$201M

Sector Composition

Rank Sector Weight
1 Healthcare 49.67%
2 Materials 13.6%
3 Industrials 9.34%
4 Communication Services 5.71%
5 Technology 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENDP
76
DELISTED
Endo International plc
ENDP
-6,944,273
Closed -$481M
KSU
77
DELISTED
Kansas City Southern
KSU
-1,019,941
Closed -$92.7M
AGN
78
DELISTED
Allergan plc
AGN
-1,523,609
Closed -$414M
TERP
79
DELISTED
TerraForm Power, Inc
TERP
-1,271,149
Closed -$18.1M
APOL
80
DELISTED
Apollo Education Group Inc Class A
APOL
-6,892,084
Closed -$76.2M
SUNE
81
DELISTED
SUNEDISON, INC COM
SUNE
-9,794,331
Closed -$70.3M

Similar funds

Glenview Capital Management's Q4 2015 Portfolio in Review

As of Q4 2015, Glenview Capital Management held 81 positions worth $17.8B, down 12% from $20.2B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Glenview Capital Management withdrew a net $2.67B in Q4 2015, closing 26 positions and reducing 27 holdings. Its most notable exit was Endo International plc, an estimated $481M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 44% a quarter earlier, followed by Materials and Industrials.

Against the trend, Glenview Capital Management opened a new position in Computer Sciences worth $225M.

  • Glenview Capital Management's largest Q4 2015 buy was Computer Sciences: 6,879,290 shares worth $225M.
  • Glenview Capital Management added most to HCA Healthcare in Q4 2015, an estimated $613M increase.
  • Glenview Capital Management's biggest Q4 2015 reduction was Thermo Fisher Scientific, cutting an estimated $344M.
  • Glenview Capital Management fully exited Endo International plc in Q4 2015, selling an estimated $481M.
  • Glenview Capital Management's ten largest holdings make up 51% of its $17.8B portfolio in Q4 2015.
  • Glenview Capital Management opened 3 new positions and closed 26 in Q4 2015.
  • Glenview Capital Management's portfolio value fell 12% quarter-over-quarter to $17.8B.

Based on Glenview Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.